pyrroles has been researched along with Cancer of Spleen in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergman, P; Clifford, C; Crawford-Jakubiak, M; Gardner, HL; Garrett, LD; Henry, C; Klein, MK; Locke, J; London, CA; Nguyen, S; Portela, RA; Rosenberg, MP; Thamm, DH; Vail, DM | 1 |
Barragán, M; Campàs, C; Coll-Mulet, L; Cosialls, AM; de Frias, M; Domingo, A; Gil, J; Iglesias-Serret, D; Pons, G; Santidrián, AF | 1 |
Cuneo, KC; Fu, A; Geng, L; Osusky, KL | 1 |
Bargetzi, M; Puric, E; Schönenberger, A; Sendi, P | 1 |
Chandra, P; Hausmann, S; Metz, A | 1 |
5 other study(ies) available for pyrroles and Cancer of Spleen
Article | Year |
---|---|
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Doxorubicin; Female; Hemangiosarcoma; Indoles; Male; Pyrroles; Splenic Neoplasms | 2015 |
Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
Topics: Antimycin A; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzopyrans; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Indoles; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Nitriles; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Splenic Neoplasms | 2006 |
Effects of vascular endothelial growth factor receptor inhibitor SU5416 and prostacyclin on murine lung metastasis.
Topics: Animals; Carcinoma, Lewis Lung; Cell Adhesion; Cells, Cultured; Disease Progression; Epoprostenol; Indoles; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Splenic Neoplasms | 2007 |
[Chronic lymphocytic leukemia and loss of strength in the right arm--not a typical combination].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Arm; Benzenesulfonates; Bone Neoplasms; Carcinoma, Renal Cell; Clinical Trials, Phase III as Topic; Disease Progression; Humans; Hypesthesia; Indoles; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Muscle Weakness; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Radiography, Abdominal; Radiography, Thoracic; Risk; Risk Factors; Sex Factors; Sorafenib; Splenic Neoplasms; Sunitinib; Time Factors; Tomography, X-Ray Computed | 2007 |
Inhibition of DNA and RNA polymerases of oncornaviruses and of bacteria by N-formyl-glycyl and N-formyl-alanyl derivatives of distamycin A.
Topics: Alanine; Amidines; Anti-Bacterial Agents; Centrifugation, Density Gradient; Chromatography, DEAE-Cellulose; DNA Nucleotidyltransferases; DNA-Directed RNA Polymerases; Escherichia coli; Formates; Friend murine leukemia virus; Glycine; Oligopeptides; Proteins; Pyrroles; Splenic Neoplasms; Sucrose; Templates, Genetic; Tritium | 1974 |